Curable Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Hyoung-Doo Shin
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Hyoung-Doo Shin (61 yo)
no data
Tenure
Hyoung-Doo Shin serves as the Chief Executive Officer at Curable. Inc. (formerly known as SNP Genetics Inc.).